CBLB and non-small cell lung carcinoma: Besides, we used the Kaplan-Meier plotter and found that Cbl-b overexpression was associated with a long overall survival time in NSCLC (P = 0.00072) and in LUAD (P = 0.02,), but there is not significant differences in LUSC (Figure 7).